drugset / Trial / NCT05547815

Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine

NCT05547815 ↗

Phase 4 Completed 149 enrolled Changchun Zhuoyi Biological Co., Ltd
NaSingle-groupOpen-labelPrevention

Summary

Evaluation of immune persistence after rabies vaccination in 150 people.

Timeline

Start
2019-11-11
Primary completion
2020-12-17
Completion
2021-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Freeze-dried Human Rabies Vaccine (Vero Cell) Vaccine — —

Indications